SE372536B - - Google Patents

Info

Publication number
SE372536B
SE372536B SE6915950A SE1595069A SE372536B SE 372536 B SE372536 B SE 372536B SE 6915950 A SE6915950 A SE 6915950A SE 1595069 A SE1595069 A SE 1595069A SE 372536 B SE372536 B SE 372536B
Authority
SE
Sweden
Application number
SE6915950A
Inventor
R Pheiffer
K Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE372536B publication Critical patent/SE372536B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/32Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
SE6915950A 1969-02-17 1969-11-20 SE372536B (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79999169A 1969-02-17 1969-02-17

Publications (1)

Publication Number Publication Date
SE372536B true SE372536B (xx) 1974-12-23

Family

ID=25177238

Family Applications (1)

Application Number Title Priority Date Filing Date
SE6915950A SE372536B (xx) 1969-02-17 1969-11-20

Country Status (17)

Country Link
US (1) US3496171A (xx)
AT (1) AT293618B (xx)
BE (1) BE742086A (xx)
BR (1) BR6914264D0 (xx)
CH (1) CH531006A (xx)
CS (1) CS157076B2 (xx)
CY (1) CY784A (xx)
DE (1) DE1958329C3 (xx)
ES (1) ES373868A1 (xx)
FR (1) FR2031460B1 (xx)
GB (1) GB1254148A (xx)
IE (1) IE33619B1 (xx)
IL (1) IL33326A (xx)
MY (1) MY7500052A (xx)
NL (1) NL6917696A (xx)
PL (1) PL83176B1 (xx)
SE (1) SE372536B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692781A (en) * 1971-02-26 1972-09-19 Glaxo Lab Ltd Recovery of pure cephalexin from acidic reaction mixtures
US4054738A (en) * 1975-12-22 1977-10-18 Eli Lilly And Company Sodium cefamandole crystalline forms
WO2011139254A2 (en) * 2010-05-04 2011-11-10 Mahmut Bilgic Pharmaceutical formulations compising cefuroxime axetil

Also Published As

Publication number Publication date
ES373868A1 (es) 1972-02-16
FR2031460B1 (xx) 1973-04-06
MY7500052A (en) 1975-12-31
DE1958329C3 (de) 1974-05-02
BE742086A (xx) 1970-05-25
NL6917696A (xx) 1970-08-19
DE1958329A1 (de) 1970-10-22
GB1254148A (en) 1971-11-17
BR6914264D0 (pt) 1973-02-22
PL83176B1 (xx) 1975-12-31
IE33619L (en) 1970-08-17
CH531006A (fr) 1972-11-30
CS157076B2 (xx) 1974-08-23
US3496171A (en) 1970-02-17
IL33326A0 (en) 1970-01-29
DE1958329B2 (de) 1973-09-27
CY784A (en) 1976-06-01
FR2031460A1 (xx) 1970-11-20
IL33326A (en) 1973-02-28
IE33619B1 (en) 1974-09-04
AT293618B (de) 1971-10-25

Similar Documents

Publication Publication Date Title
AU465413B2 (xx)
AU4221168A (xx)
AU450150B2 (xx)
CS149923B2 (xx)
AU2355770A (xx)
FR2031460B1 (xx)
AU442375B2 (xx)
AU470301B1 (xx)
AU427401B2 (xx)
AU417208B2 (xx)
AU470661B1 (xx)
AU425297B2 (xx)
AU414607B2 (xx)
AU5598769A (xx)
AU5079269A (xx)
CS153061B2 (xx)
CS152556B1 (xx)
CS150091B1 (xx)
AU4923469A (xx)
CS149254B1 (xx)
AU5133369A (xx)
AU5077469A (xx)
AU5109569A (xx)
AU4953367A (xx)
AU481328A (xx)